Etanercept
Etanercept, a bioengineered fusion protein derived from the human soluble tumor       necrosis factor p75 receptor, recently has been approved for use in patients with       refractory RA.
 @SUBJECT$ , a bioengineered fusion protein derived from the human soluble tumor       necrosis factor p75 receptor, recently has been approved for use  @PREDICAT$   @OBJECT$  with       refractory RA.